US Patent 8629113 CTLA4-Ig immunoadhesins

Patent 8629113 was granted and assigned to Xencor on January, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Xencor

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

86291130

Patent Inventor Names

Matthew J. Bernett0

Gregory A. Lazar0

Date of Patent

January 14, 2014

Patent Application Number

137103050

Date Filed

December 10, 2012

Patent Citations Received

‌

US Patent 11952427 Anti-CD40 antibodies and uses thereof

Patent Primary Examiner

‌

Ilia Ouspenski

Patent abstract

The present application relates to CTLA4-Ig immunoadhesins that target CD80 and CD86, and their use, particularly for therapeutic purposes.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8629113 CTLA4-Ig immunoadhesins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API